Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rockwell Medical Q4 Adjusted EPS $0.02 May Not Be Comparable To $(0.07) Estimate, Sales $22.10M Miss $22.63M Estimate

Author: Benzinga Newsdesk | March 21, 2024 06:03am
Rockwell Medical (NASDAQ:RMTI) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.07) by 128.57 percent. This is a 166.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $22.10 million which missed the analyst consensus estimate of $22.63 million by 2.34 percent. This is a 14.43 percent increase over sales of $19.31 million the same period last year.

Posted In: RMTI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist